Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial

Fig. 3

ACR30–100 and JIA inactive disease response rates by visit (hybrid imputation method). Note: For patients with PsA, values for ACR30 and ACR50 overlap completely for all visits after week 24. Abbreviations: eoJIA, extended oligoarticular juvenile idiopathic arthritis; ERA, enthesitis-related arthritis; PsA, psoriatic arthritis

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us